These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35913746)

  • 1. Virulence factors of Malassezia strains isolated from pityriasis versicolor patients and healthy individuals.
    Chebil W; Rhimi W; Haouas N; Romano V; Belgacem S; Belhadj Ali H; Babba H; Cafarchia C
    Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35913746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants.
    Rhimi W; Chebil W; Ugochukwu ICI; Babba H; Otranto D; Cafarchia C
    Med Mycol; 2022 Dec; 61(1):. PubMed ID: 36626926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Assessment of Azole and Amphotericin B Susceptibilities of
    Chebil W; Haouas N; Eskes E; Vandecruys P; Belgacem S; Belhadj Ali H; Babba H; Van Dijck P
    J Fungi (Basel); 2022 Sep; 8(9):. PubMed ID: 36135684
    [No Abstract]   [Full Text] [Related]  

  • 4. Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.
    Carreira A; Ferreira JB; Pereira I; Ferreira J; Filipe P; Ferreira RB; Monteiro S
    J Med Microbiol; 2018 Feb; 67(2):198-207. PubMed ID: 29388537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and Quantification of Virulence Factors in
    Hadrich I; Khemekhem N; Neji S; Trablesi H; Ilahi A; Sellami H; Makni F; Ayadi A
    Pol J Microbiol; 2022 Dec; 71(4):529-538. PubMed ID: 36473111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular phospholipase activity of Malassezia strains isolated from individuals with and without dermatological disease.
    Pini G; Faggi E
    Rev Iberoam Micol; 2011; 28(4):179-82. PubMed ID: 21645629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential lipase virulence in Malassezia furfur dimorphism isolated from pityriasis versicolor patients and healthy individuals.
    Thammasit P; Laliam A; Chaicumpar K; Pruksaphon K; Nosanchuk JD; Youngchim S
    Mycoses; 2023 Jun; 66(6):540-549. PubMed ID: 36840378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence and Antifungal Susceptibility of
    Aneke CI; Rhimi W; Hubka V; Otranto D; Cafarchia C
    Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33809233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the antibiofilm efficacy of cinnamaldehyde against Malassezia globosa associated pityriasis versicolor.
    Liu MM; Zhao YJ; Boekhout T; Wang QM
    Phytomedicine; 2024 Jul; 130():155542. PubMed ID: 38823343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis versicolor.
    Gupta AK; Bluhm R; Summerbell R
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):19-33. PubMed ID: 11952286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology,
    Li W; Zhang ZW; Luo Y; Liang N; Pi XX; Fan YM
    J Med Microbiol; 2020 Mar; 69(3):436-442. PubMed ID: 32068525
    [No Abstract]   [Full Text] [Related]  

  • 12. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
    Brilhante RSN; Rocha MGD; Guedes GMM; Oliveira JS; Araújo GDS; España JDA; Sales JA; Aguiar L; Paiva MAN; Cordeiro RA; Pereira-Neto WA; Pinheiro AQ; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
    Vet Microbiol; 2018 Jul; 220():47-52. PubMed ID: 29885800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of anti- pityriasis versicolor therapy that preserves healthy mycobiome.
    Dyląg M; Leniak E; Gnat S; Szepietowski JC; Kozubowski L
    BMC Dermatol; 2020 Sep; 20(1):9. PubMed ID: 32993612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Part 1: Understanding the role of
    Ugochukwu ICI; Rhimi W; Chebil W; Rizzo A; Tempesta M; Giusiano G; Tábora RFM; Otranto D; Cafarchia C
    Expert Rev Anti Infect Ther; 2023; 21(12):1327-1338. PubMed ID: 37883074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microreview of Pityriasis versicolor and Malassezia species.
    Morishita N; Sei Y
    Mycopathologia; 2006 Dec; 162(6):373-6. PubMed ID: 17146580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activities of azole agents against the Malassezia species.
    Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
    Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal activity of Myrtus communis against Malassezia sp. isolated from the skin of patients with pityriasis versicolor.
    Barac A; Donadu M; Usai D; Spiric VT; Mazzarello V; Zanetti S; Aleksic E; Stevanovic G; Nikolic N; Rubino S
    Infection; 2018 Apr; 46(2):253-257. PubMed ID: 29159502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal Susceptibility Testing of Malassezia spp. with an Optimized Colorimetric Broth Microdilution Method.
    Leong C; Buttafuoco A; Glatz M; Bosshard PP
    J Clin Microbiol; 2017 Jun; 55(6):1883-1893. PubMed ID: 28381607
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Sharma A; Rabha D; Ahmed G
    Indian J Dermatol Venereol Leprol; 2017; 83(2):249-251. PubMed ID: 27852993
    [No Abstract]   [Full Text] [Related]  

  • 20. Malassezia infections: a medical conundrum.
    Pedrosa AF; Lisboa C; Gonçalves Rodrigues A
    J Am Acad Dermatol; 2014 Jul; 71(1):170-6. PubMed ID: 24569116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.